Literature DB >> 15243550

Endoscopic treatment of laryngeal and tracheal stenosis-has mitomycin C improved the outcome?

Ilya Perepelitsyn1, Stanley M Shapshay.   

Abstract

OBJECTIVE: The management of laryngeal and tracheal stenosis remains a challenging problem despite advances in endoscopic surgical techniques. Scar formation and restenosis is the main cause of failure, and this study assesses the efficacy of two adjuvant treatments: endoscopic steroid injection and topical mitomycin C application. Study design and setting This is a retrospective cohort study comparing the efficacy of 3 endoscopic techniques: (1) carbon dioxide (CO(2)) laser incisions with bronchoscopic dilatation, (2) CO(2) laser with dilatation followed by steroid injection into the stenotic area, and (3) CO(2) laser with dilatation followed by topical application of mitomycin C. Included in the statistical analysis were 47 procedures performed by the senior investigator in a tertiary medical center between 1994 and 2001 based on their success or failure.
RESULTS: The percentages of successful outcomes in the study groups were 15%, 18.2%, and 75% with the CO(2) laser, CO(2) laser with steroid injection, and CO(2) laser with mitomycin C, respectively. Statistical comparisons reveal that the differences in outcomes were statistically significant (P < 0.05) between the mitomycin group and each of the other two treatment groups, whereas there was no statistically significant difference between the laser only and laser with steroid groups. There were no complications noted with the use of adjuvant medications.
CONCLUSION: These patient group results indicate a statistically significant increase, from <20% to 75%, in the success rate of endoscopic treatment of acquired upper airway stenosis when topical mitomycin C is added to the treatment regimen. No benefit has been demonstrated for using intraoperative local steroid injections as an adjunct to laser treatment. Clinical significance Mitomycin C appears to be an effective and safe adjuvant treatment in the endoscopic management of laryngeal and tracheal stenosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243550     DOI: 10.1016/S0194-5998(04)01136-2

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  10 in total

1.  The therapy with ethosomes containing 5-fluorouracil for laryngotracheal stenosis in rabbit models.

Authors:  Xiaohui Mao; Xuefeng Cheng; Zheng Zhang; Zhaoyan Wang; Zhentao Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-21       Impact factor: 2.503

2.  Tracheal resection for tracheal stenosis.

Authors:  Aayla Jamil; Sasha Still; Gary S Schwartz; Eitan Podgaetz; David P Mason
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-10-25

3.  CO(2) laser treatment of laryngeal stenoses after reconstructive laryngectomies with cricohyoidopexy, cricohyoidoepiglottopexy or tracheohyoidoepiglottopexy.

Authors:  Marco Lucioni; Gino Marioni; Marco Mangialaio; Giuseppe Rizzotto
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-27       Impact factor: 2.503

4.  Management of Post-traumatic Laryngotracheal Stenosis: Our Experience.

Authors:  Vinod T Kandakure; Swati Mishra; Vaibhav J Lahane
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-12-03

5.  Endoscopic cold incision, balloon dilation, mitomycin C application, and steroid injection for adult laryngotracheal stenosis.

Authors:  Noah P Parker; Dipankar Bandyopadhyay; Stephanie Misono; George S Goding
Journal:  Laryngoscope       Date:  2012-10-19       Impact factor: 3.325

6.  Treatment for adult idiopathic and Wegener-associated subglottic stenosis.

Authors:  Haralampos Gouveris; Niki Karaiskaki; Dimitrios Koutsimpelas; Cheerasook Chongolwatana; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-07       Impact factor: 2.503

7.  Mitomycin C in the endoscopic treatment of tracheal stenosis: a prospective cohort study.

Authors:  Daniele Cristina Cataneo; Aglaia Moreira Garcia Ximenes; Antônio José Maria Cataneo
Journal:  J Bras Pneumol       Date:  2018 Nov-Dec       Impact factor: 2.624

8.  Transoral management of adult benign laryngeal stenosis.

Authors:  Fabiola Incandela; Francesco Missale; Francesco Mora; Filippo Marchi; Ivana Fiz; Cesare Piazza; Giorgio Peretti
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-23       Impact factor: 2.503

Review 9.  Topical use of MMC in the upper aerodigestive tract: a review on the side effects.

Authors:  Egbert J D Veen; Frederik G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-17       Impact factor: 2.503

Review 10.  Idiopathic subglottic stenosis: a review.

Authors:  Carlos Aravena; Francisco A Almeida; Sanjay Mukhopadhyay; Subha Ghosh; Robert R Lorenz; Sudish C Murthy; Atul C Mehta
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.